EUVIMEDEUVIMED entdecken
Fallbericht

Efficacy of upadacitinib in the achievement of clinical and endoscopic remission in hospitalized patients with ulcerative colitis

Naohiro Nakamura, Yusuke Honzawa, Takuya Ohtsu, Yasuki Sano, Yuka Ito, Norimasa Fukata, Toshiro Fukui, Makoto Naganuma

Clinical Journal of Gastroenterology · 2024-08 · 17 (4) · 654-657

DOI: 10.1007/s12328-024-01976-1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Journal of Gastroenterology, online erschienen am 29.04.2024. Verfasst von Naohiro Nakamura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, 2-5-1, Shinmachi, Hirakata, Osaka, 573…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Janus kinase (JAK) inhibitors have been developed and are clinically available for management of active UC patients although most studies have been conducted for the outpatients and few studies have demonstrated its efficacy in endoscopic and histological remission of hospitalized patients with UC. The aim of the present study was to investigate the efficacy of upadacitinib, which is a novel selective JAK1 inhibitor, in the treatment of ulcerative colitis. We present the cases of three hospitalized patients with ulcerative colitis who achieved clinical remission after significant and rapid improvement with upadacitinib. While upadacitinib was used as the second-line treatment for patients with insufficient treatment effects for corticosteroids or ustekinumab, a patient received it just after admission because they were steroid dependent and previously used advanced therapy before hospitalization. All patients demonstrated rapid clinical responses within 7 days and the partial Mayo scores were 0 at week 8. All patients achieved confirmed endoscopic and histological remissions. We conclude that upadacitinib is a potential treatment option for hospitalized patients with an inadequate response to other biologics and JAK inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHeterocyclic Compounds, 3-RingHumansMaleFemaleMiddle AgedAdultRemission InductionHospitalizationJanus Kinase InhibitorsColonoscopyTreatment Outcome

Stichwörter der Autor:innen

JAK–STAT pathwayUlcerative colitisUpadacitinib

Substanzen

upadacitinibHeterocyclic Compounds, 3-RingJanus Kinase Inhibitors

Autor:innen und Institutionen

  • Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, 2-5-1, Shinmachi, Hirakata, Osaka, 573-1010, Japan.
  • Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, 2-5-1, Shinmachi, Hirakata, Osaka, 573-1010, Japan. naganuma@hirakata.kmu.ac.jp.

Zitieren

APA

Nakamura, N., Honzawa, Y., Ohtsu, T., Sano, Y., Ito, Y., Fukata, N., Fukui, T., & Naganuma, M. (2024). Efficacy of upadacitinib in the achievement of clinical and endoscopic remission in hospitalized patients with ulcerative colitis. Clinical Journal of Gastroenterology, 17(4), 654-657. https://doi.org/10.1007/s12328-024-01976-1

Vancouver

Nakamura N, Honzawa Y, Ohtsu T, Sano Y, Ito Y, Fukata N, et al. Efficacy of upadacitinib in the achievement of clinical and endoscopic remission in hospitalized patients with ulcerative colitis. Clinical Journal of Gastroenterology. 2024;17(4):654-657. doi:10.1007/s12328-024-01976-1

BibTeX
@article{Nakamura2024,
  author = {Nakamura, Naohiro and Honzawa, Yusuke and Ohtsu, Takuya and Sano, Yasuki and Ito, Yuka and Fukata, Norimasa and Fukui, Toshiro and Naganuma, Makoto},
  title = {Efficacy of upadacitinib in the achievement of clinical and endoscopic remission in hospitalized patients with ulcerative colitis},
  journal = {Clinical Journal of Gastroenterology},
  year = {2024},
  volume = {17},
  number = {4},
  pages = {654--657},
  doi = {10.1007/s12328-024-01976-1}
}
Kostenlos starten →